Results 61 to 70 of about 386,297 (93)

Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease

, 2020
Vladimı́r Frecer, Stanislav Miertuš
openalex   +2 more sources

SARS‐CoV heptad repeat 2 is a trimer of parallel helices

, 2011
Jessica Celigoy, Benjamin E. Ramirez, Michael Caffrey   +2 more
openalex   +1 more source

SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species

, 2020
Dhiraj Kumar Singh, Shashank Ganatra, Bindu Singh, Journey Cole, Kendra J. Alfson, Elizabeth A. Clemmons, Michal Gaži, Olga González, Ruby A. Escobedo, Tae‐Hyung Lee, Ayan Chatterjee, Yenny Goez-Gazi, Riti Sharan, Rajesh Thippeshappa, Maya Gough, Cynthia Alvarez, Alyssa Blakley, Justin Ferdin, Carmen Bartley, Hilary Staples, Laura M. Parodi, Jessica Callery, Amanda Mannino, Benjamin Klaffke, Priscilla Escareno, Roy N. Platt, Vida Hodara, Julia M. Scordo, A. Oyejide, Dharani K. Ajithdoss, Richard Copin, Alina Baum, Christos A. Kyratsous, Xavier Álvarez, Bruce Rosas, Mushtaq Ahmed, Anna Goodroe, John Dutton, Shannan Hall-Ursone, Patrice A. Frost, Andra K. Voges, Corinna N. Ross, Ken Sayers, Christopher Y. Chen, Cory R. A. Hallam, Shabaana A. Khader, Makedonka Mitreva, Timothy J. C. Anderson, Luis Martínez‐Sobrido, Jean L. Patterson, Joanne Turner, Jordi B. Torrelles, Edward J. Dick, Kathleen M. Brasky, Larry S. Schlesinger, Luis D. Giavedoni, Ricardo Carrion, Deepak Kaushal   +57 more
openalex   +1 more source

EVIDENCIAS CIENTÍFICAS DE LA SOBREVIVENCIA DEL SARS COV-2 EN AGUA DE GRIFO NO CONTAMINADA Y EN AGUAS RESIDUALES NO TRATADAS

, 2012
Martín Mundo
openalex   +2 more sources

Posibles factores protectores de la infección por SARS-CoV-2 en una paciente vulnerable: a propósito de un caso

, 2020
A. Alcántara Montero, S.R. Pacheco de Vasconcelos, África Holguín, M.T. Matsuki Martín de Prado   +3 more
openalex   +1 more source

Screening of World Approved Drugs against Highly Dynamical Spike Glycoprotein SARS-CoV-2 using CaverDock and Machine Learning

, 2020
Gaspar Pinto, Ondřej Vávra, Sérgio M. Marques, Jiří Filipovič, David Bednář, Jir̆ı́ Damborský   +5 more
openalex   +1 more source

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

, 2020
Baoqing Sun, Ying Feng, Xiaoneng Mo, Peiyan Zheng, Qian Wang, Pingchao Li, Ping Peng, Xiaoqing Liu, Zhilong Chen, Huimin Huang, Fan Zhang, Wenting Luo, Xuefeng Niu, Peiyu Hu, Longyu Wang, Hui Peng, Zhifeng Huang, Liqiang Feng, Feng Li, Fuchun Zhang, Fang Li, Nanshan Zhong, Ling Chen   +22 more
openalex   +2 more sources

SARS-CoV-2 Infectivity and Neurological Targets in the Brain [PDF]

, 2020
Walter J. Lukiw, Aileen I. Pogue, James M. Hill   +2 more
openalex   +1 more source

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 [PDF]

, 2020
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li, Ke Xu   +24 more
openalex   +1 more source

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases [PDF]

The SARS-CoV-2 pandemic has caused nearly 7,000,000 deaths globally. The Target-to-B! COVID-19 study, a multicentre cohort study, examined SARS-CoV-2 vaccine efficacy in immune-mediated inflammatory disease (IMID) patients treated with immunosuppressants.
Stalman, E.W.
core